Related references
Note: Only part of the references are listed.Identification of a region required for TSC1 stability by functional analysis of TSC1 missense mutations found in individuals with tuberous sclerosis complex
Melika Mozaffari et al.
BMC MEDICAL GENETICS (2009)
Proteasomal and Genetic Inactivation of the NF1 Tumor Suppressor in Gliomagenesis
Lauren T. McGillicuddy et al.
CANCER CELL (2009)
Signaling Events Downstream of Mammalian Target of Rapamycin Complex 2 Are Attenuated in Cells and Tumors Deficient for the Tuberous Sclerosis Complex Tumor Suppressors
Jingxiang Huang et al.
CANCER RESEARCH (2009)
Cell of Origin and Microenvironment Contribution for NF1-Associated Dermal Neurofibromas
Lu Q. Le et al.
CELL STEM CELL (2009)
The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation
William E. Tidyman et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2009)
Gliomas in patients with neurofibromatosis type 1
Anne C. Albers et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
Malignant peripheral nerve sheath tumour (MPNST): the clinical implications of cellular signalling pathways
Daniela Katz et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
Microarray Analyses Reveal Regional Astrocyte Heterogeneity with Implications for Neurofibromatosis Type 1 (NF1)-Regulated Glial Proliferation
Tu-Hsueh Yeh et al.
GLIA (2009)
Efficacy of combined inhibition of mTOR and ERK/MAPK pathways in treating a tuberous sclerosis complex cell model
Ruifang Mi et al.
JOURNAL OF GENETICS AND GENOMICS (2009)
Ral Overactivation in Malignant Peripheral Nerve Sheath Tumors
Vidya Bodempudi et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1
Hilde Brems et al.
LANCET ONCOLOGY (2009)
Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas
T. Tucker et al.
JOURNAL OF MEDICAL GENETICS (2009)
From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis
D. Ehninger et al.
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2009)
Induction of abnormal proliferation by nonmyelinating Schwann cells triggers neurofibroma formation
Huarui Zheng et al.
CANCER CELL (2008)
The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells
Nancy M. Joseph et al.
CANCER CELL (2008)
Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma
Balazs Hegedus et al.
CANCER RESEARCH (2008)
Nf1-Dependent Tumors Require a Microenvironment Containing Nf1+/- and c-kit-Dependent Bone Marrow
Feng-Chun Yang et al.
CELL (2008)
TORC1 is essential for NF1-associated malignancies
Cory M. Johannessen et al.
CURRENT BIOLOGY (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Clinical and molecular aspects of RAS related disorders
E. Denayer et al.
JOURNAL OF MEDICAL GENETICS (2008)
Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications
ON Gottfried et al.
NEUROSURGERY (2006)
The NF1 tumor suppressor critically regulates TSC2 and mTOR
CM Johannessen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors
M Upadhyaya et al.
HUMAN MUTATION (2004)
Using mice to decipher the molecular genetics of brain tumors
G Hesselager et al.
NEUROSURGERY (2003)
Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1(+/-) mast cells
FC Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Losses in chromosomes 17, 19, and 22q in neurofibromatosis type 1 and sporadic neurofibromas: a comparative genomic hybridization analysis
T Koga et al.
CANCER GENETICS AND CYTOGENETICS (2002)
Neurofibromas in NF1: Schwann cell origin and role of tumor environment
Y Zhu et al.
SCIENCE (2002)
Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors
S Birindelli et al.
LABORATORY INVESTIGATION (2001)
Tumorigenic properties of neurofibromin-deficient neurofibroma schwann cells
D Muir et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells
GA Mashour et al.
ONCOGENE (2001)
Schwann cells harbor the somatic NF1 mutation in neurofibromas:: evidence of two different Schwann cell subpopulations
E Serra et al.
HUMAN MOLECULAR GENETICS (2000)
Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the CAP-related domain
R Fahsold et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1
I Eisenbarth et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1
E Ars et al.
HUMAN MOLECULAR GENETICS (2000)
Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo
DA Ingram et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
A search for evidence of somatic mutations in the NF1 gene
AM John et al.
JOURNAL OF MEDICAL GENETICS (2000)
Share Paper
